BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38612467)

  • 1. Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model.
    Abe T; Miyazaki M; Sako N; Kanezaki S; Tsubouchi Y; Kaku N
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal intermittent administration interval of parathyroid hormone 1-34 for bone morphogenetic protein-induced bone formation in a rat spinal fusion model.
    Abe T; Miyazaki M; Ishihara T; Kanezaki S; Tsubouchi Y; Tsumura H
    JOR Spine; 2021 Sep; 4(3):e1168. PubMed ID: 34611590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
    Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
    Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intermittent Administration of Teriparatide (Parathyroid Hormone 1-34) on Bone Morphogenetic Protein-Induced Bone Formation in a Rat Model of Spinal Fusion.
    Morimoto T; Kaito T; Kashii M; Matsuo Y; Sugiura T; Iwasaki M; Yoshikawa H
    J Bone Joint Surg Am; 2014 Jul; 96(13):e107. PubMed ID: 24990981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model.
    Doi Y; Miyazaki M; Yoshiiwa T; Hara K; Kataoka M; Tsumura H
    Bone; 2011 Oct; 49(4):777-82. PubMed ID: 21777711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the effects of exfoliated carbon nanofibers using bone morphogenetic protein in a rat spinal fusion model.
    Notani N; Miyazaki M; Toyoda M; Kanezaki S; Ishihara T; Tsumura H
    J Orthop Res; 2018 Nov; 36(11):2892-2900. PubMed ID: 29917272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the effects of intermittent parathyroid hormone (1-34) by bone morphogenetic protein in a rat femoral open fracture model.
    Kanezaki S; Miyazaki M; Ishihara T; Notani N; Abe T; Tsubouchi Y; Kataoka M; Tsumura H
    J Orthop Surg Res; 2019 Nov; 14(1):403. PubMed ID: 31783887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
    J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abaloparatide Enhances Fusion and Bone Formation in a Rabbit Spinal Arthrodesis Model.
    Morse KW; Moore H; Kumagai H; Hahn W; Koo A; Meyers KN; Bouxsein ML; Brooks DJ; Lanske B; Iyer S; Cunningham M
    Spine (Phila Pa 1976); 2022 Nov; 47(22):1607-1612. PubMed ID: 35943233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
    Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
    Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
    Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sustained release of recombinant human bone morphogenetic protein-2 combined with stromal vascular fraction cells in promoting posterolateral spinal fusion in rat model].
    Yuan W; Zheng J; Qian J; Zhou X; Wang M; Wang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2017 Jul; 31(7):862-869. PubMed ID: 29798533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
    Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
    Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
    Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
    J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting.
    Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR
    Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
    Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Coralline Hydroxyapatite Implant with Recombinant Human Bone Morphogenetic Protein-2-Loaded Chitosan Nanospheres and Its Osteogenic Efficacy.
    Xia YJ; Wang W; Xia H; Huang XH; Deng FP; Ying QS; Yu X; Li LH; Wang JH; Zhang Y
    Orthop Surg; 2020 Dec; 12(6):1947-1953. PubMed ID: 33080108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats.
    Arlt H; Besschetnova T; Ominsky MS; Fredericks DC; Lanske B
    JOR Spine; 2021 Mar; 4(1):e1132. PubMed ID: 33778406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.